Latest Insider Transactions at Hanger, Inc. (HNGR)
This section provides a real-time view of insider transactions for Hanger, Inc. (HNGR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HANGER, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HANGER, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
Peter A Stoy EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,863
-3.95%
|
$35,397
$19.41 P/Share
|
|
Mar 08
2022
|
Scott Ranson EVP, Chief Info Officer * |
SELL
Payment of exercise price or tax liability
|
Direct |
2,512
-2.18%
|
$47,728
$19.41 P/Share
|
|
Mar 08
2022
|
Regina A Weger President, SPS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-3.69%
|
$20,235
$19.41 P/Share
|
|
Mar 08
2022
|
James H Campbell SVP, Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-7.52%
|
$76,000
$19.52 P/Share
|
|
Mar 07
2022
|
Vinit K Asar President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
69,110
+7.21%
|
-
|
|
Mar 07
2022
|
Peter A Stoy EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,943
+30.76%
|
-
|
|
Mar 07
2022
|
Scott Ranson EVP, Chief Info Officer * |
BUY
Grant, award, or other acquisition
|
Direct |
7,199
+5.88%
|
-
|
|
Mar 07
2022
|
Keri Jolly SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,414
+13.31%
|
-
|
|
Mar 07
2022
|
Gabrielle B. Adams Vice President Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
5,760
+7.69%
|
-
|
|
Mar 07
2022
|
Regina A Weger President, SPS |
BUY
Grant, award, or other acquisition
|
Direct |
5,236
+15.35%
|
-
|
|
Mar 07
2022
|
Mitchell D Dobson SVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,451
+9.89%
|
-
|
|
Mar 07
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,597
+7.22%
|
-
|
|
Mar 07
2022
|
Thomas E Hartman SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,733
+6.99%
|
-
|
|
Mar 07
2022
|
James H Campbell SVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,283
+10.57%
|
-
|
|
Feb 15
2022
|
Vinit K Asar President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
66,439
+7.5%
|
-
|
|
Feb 15
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
13,842
-5.13%
|
-
|
|
Feb 15
2022
|
Thomas E Hartman SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,880
+4.72%
|
-
|
|
Feb 15
2022
|
Scott Ranson EVP, Chief Info Officer * |
BUY
Grant, award, or other acquisition
|
Direct |
4,615
+4.1%
|
-
|
|
Feb 15
2022
|
Keri Jolly SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,195
+10.6%
|
-
|
|
Feb 15
2022
|
Mitchell D Dobson SVP, Chief Compliance Officer |
SELL
Grant, award, or other acquisition
|
Direct |
2,517
-6.52%
|
-
|
|
Feb 15
2022
|
James H Campbell SVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,692
+7.3%
|
-
|
|
Feb 15
2022
|
Gabrielle B. Adams Vice President Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
3,356
+5.03%
|
-
|
|
Feb 15
2022
|
Regina A Weger President, SPS |
BUY
Grant, award, or other acquisition
|
Direct |
3,356
+12.43%
|
-
|
|
Feb 15
2022
|
Peter A Stoy EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,712
+20.4%
|
-
|
|
Dec 16
2021
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-3.49%
|
$148,750
$17.3 P/Share
|
|
Sep 16
2021
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-3.37%
|
$183,750
$21.86 P/Share
|
|
Sep 07
2021
|
Vinit K Asar President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-0.98%
|
$330,000
$22.57 P/Share
|
|
Jun 21
2021
|
Keri Jolly SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-3.34%
|
$25,824
$24.61 P/Share
|
|
Jun 16
2021
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-3.26%
|
$218,750
$25.5 P/Share
|
|
Jun 07
2021
|
Vinit K Asar President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-1.92%
|
$375,000
$25.86 P/Share
|
|
May 27
2021
|
Scott Ranson EVP, Chief Info Officer * |
SELL
Payment of exercise price or tax liability
|
Direct |
32,702
-24.03%
|
$817,550
$25.51 P/Share
|
|
May 27
2021
|
Scott Ranson EVP, Chief Info Officer * |
BUY
Exercise of conversion of derivative security
|
Direct |
47,494
+25.87%
|
$569,928
$12.77 P/Share
|
|
May 26
2021
|
Christopher B Begley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+7.62%
|
-
|
|
May 26
2021
|
Stephen E Hare Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+5.35%
|
-
|
|
May 26
2021
|
Asif Ahmad Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+8.26%
|
-
|
|
May 26
2021
|
Kathryn M Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+9.52%
|
-
|
|
May 26
2021
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+8.65%
|
-
|
|
May 26
2021
|
Richard Pettingill Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+7.44%
|
-
|
|
May 26
2021
|
Mark M Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+33.92%
|
-
|
|
May 26
2021
|
John T Fox Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+14.01%
|
-
|
|
May 26
2021
|
Thomas C Freyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,484
+14.01%
|
-
|
|
May 11
2021
|
Thomas E Hartman SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
49,789
-27.39%
|
$1,244,725
$25.02 P/Share
|
|
May 11
2021
|
Thomas E Hartman SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
70,818
+28.03%
|
$849,816
$12.77 P/Share
|
|
Apr 30
2021
|
Gabrielle B. Adams Vice President Accounting |
SELL
Open market or private sale
|
Direct |
20,938
-25.86%
|
$523,450
$25.03 P/Share
|
|
Apr 30
2021
|
Gabrielle B. Adams Vice President Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
20,938
+20.55%
|
$251,256
$12.77 P/Share
|
|
Mar 16
2021
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-3.16%
|
$201,250
$23.93 P/Share
|
|
Mar 10
2021
|
Vinit K Asar President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-1.88%
|
$345,000
$23.22 P/Share
|
|
Mar 09
2021
|
Gabrielle B. Adams Vice President Accounting |
SELL
Payment of exercise price or tax liability
|
Direct |
1,754
-2.84%
|
$40,342
$23.46 P/Share
|
|
Mar 09
2021
|
Vinit K Asar President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,804
-3.25%
|
$616,492
$23.46 P/Share
|
|
Mar 09
2021
|
James H Campbell SVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,302
-2.93%
|
$29,946
$23.46 P/Share
|